Full Paper
(m, 4 H), 3.74 (s, 3 H), 1.81 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 171.1 (CO), 168.1 (C), 167.9 (C), 138.6 (C), 138.2 (C), 136.0 (CH),
134.8 (2 CH), 132.2 (C), 131.3 (2 C), 129.1 (2 CH), 129.0 (2 CH), 128.6
(2 CH), 127.9 (CH), 127.8 (2 CH), 123.9 (CH), 123.6 (2 CH), 122.1 (CH),
96.9 (CH), 75.2 (CH), 73.7 (CH2), 73.6 (CH), 70.3 (CH), 70.2 (CH2), 69.9
5 H), 3.83 (s, 3 H), 3.63–3.55 (m, 4 H), 3.50–3.44 (m, 2 H), 1.82 (s, 3
H), 1.75 (s, 3 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.2 (CO), 170.1
(CO), 167.9 (CO), 154.0 (C), 149.0 (C), 143.2 (C), 143.0 (C), 141.25 (C),
141.23 (C), 138.4 (C), 138.2 (C), 137.5 (C), 136.4 (CH), 134.5 (2 CH),
134.3 (2 CH), 131.2 (2 C), 131.3 (2 C), 129.3 (2 CH), 129.2 (2 CH),
129.0 (CH), 128.4 (3 CH), 128.2 (CH), 128.0 (CH), 127.9 (CH), 127.7
(CH), 127.6 (2 CH), 127.5 (CH), 127.4 (2 CH), 127.23 (CH), 127.20 (CH),
(CH2), 54.8 (CH), 53.0 (CH2), 36.3 (CH3), 20.8 (CH3) ppm. 19F NMR
1
(CDCl3): δ = –72.08 (d, JP, F = 712 Hz, PF6–) ppm. IR (film): ν = 3155,
˜
2873, 1775, 1734, 1712, 1386, 1231, 1043, 972, 722 cm–1. MS (ESI): 125.3 (CH), 125.09 (CH), 125.07 (CH), 123.7 (CH), 123.5 (2 CH), 122.0
m/z (%) = 626 (100) [M – PF6]+. HRMS (ESI-TOF): calcd. for
(CH), 120.07 (CH), 120.04 (CH), 97.0 (CH), 96.1 (CH), 74.4 (CH), 74.1
(CH), 73.4 (CH), 72.8 (CH2), 72.5 (CH), 70.9 (CH), 70.7 (CH), 70.2 (CH2),
69.7 (CH2), 68.4 (2 CH2), 67.7 (CH2), 55.1 (CH), 54.7 (CH), 53.1 (CH2),
C35H36N3O8 [M – PF6]+ 626.2502; found 626.2493.
2-Methyl-5-(tert-butyl)phenyl 3-O-Acetyl-6-O-benzyl-2-deoxy-4-
O-fluorenylmethyloxycarbonyl-2-phthalimido-1-thio-ꢀ-D-gluco-
46.5 (CH), 36.4 (CH3), 20.6 (CH3), 20.4 (CH3) ppm. 3 carbon resonan-
1
ces [N(CO)2] were missing. 19F NMR (CDCl3): δ = –72.37 (d, JP, F
=
pyranoside (15): Thioglucoside 7[18a] (710 mg, 1.18 mmol,
1.0 equiv.) and FmocCl (609 mg, 2.36 mmol, 2.0 equiv.) were stirred
in pyridine (6.1 mL) at room temperature for 4 h. The reaction mix-
ture was then filtered, and the volatiles were evaporated under re-
duced pressure. The crude product was purified by chromatography
on silica gel (heptane/EtOAc, 9:1 to 5:5) to give compound 15
712 Hz, PF6–) ppm. IR (film): ν = 2947, 1774, 1748, 1714, 1385, 1257,
˜
1224, 1045, 1029, 838, 720 cm–1. MS (ESI): m/z (%) = 1271 (100) [M
–
PF6]+. HRMS (ESI-TOF): calcd. for C73H67N4O17 [M PF6]+
–
1271.4501; found 1271.4564.
4-(1-Methyl-3-methylimidazolium)benzyl 3-O-Acetyl-6-O-benz-
-glucopyranosyl-(1→4)-3-O-
acetyl-6-O-benzyl-2-deoxy-2-phthalimido-ꢀ- -glucopyranoside
7.60–7.52 (m, 3 H), 7.45–7.37 (m, 2 H), 7.36–7.29 (m, 6 H), 7.27–7.20 Hexafluorophosphate (17): Fmoc-disaccharide 16 (60 mg,
(802 mg, 82 %) as a white powder. [α]D20 = –47.3 (c = 1.0, CHCl3). 1H yl-2-deoxy-2-phthalimido-ꢀ-
NMR (300 MHz, CDCl3): δ = 7.92–7.87 (m, 2 H), 7.80–7.74 (m, 4 H),
D
D
(m, 2 H), 7.10–7.05 (m, 1 H), 5.95 (dd, J = 10.5, J = 9.0 Hz, 1 H), 5.72
(d, J = 10.5 Hz, 1 H), 5.02 (dd, J = 10.0, J = 9.0 Hz, 1 H), 4.59 (AB
system, J = 12.0 Hz, 1 H), 4.53 (AB system, J = 12.0 Hz, 1 H), 4.46 (t,
J = 10.5 Hz, 1 H), 4.40–4.22 (m, 2 H), 4.21–4.13 (m, 1 H), 3.95 (td,
J = 10.0, J = 4.5 Hz, 1 H), 3.73 (d, J = 4.0 Hz, 2 H), 2.20 (s, 3 H), 1.81
0.04 mmol, 1.0 equiv.) and Et3N (0.6 mL, 4.45 mmol) were stirred in
dry dichloromethane (5.0 mL) at room temperature for 3 h. The
solvents were then evaporated, and then coevaporated with tolu-
ene (3 × 5 mL). The residue was washed with Et2O (3 × 5 mL) and
a mixture of CH2Cl2/n-pentane (4:1; 3 × 5 mL) to give compound
(s, 3 H), 1.27 (s, 9 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.1 (CO), 17 (46 mg, 90 %) as a yellow powder. [α]D20 = –6.7 (c = 0.5, CHCl3).
154.1 (C), 149.6 (C), 143.2 (C), 143.0 (C), 141.25 (C), 141.20 (C), 137.7
(C), 137.4 (C), 134.4 (CH), 134.3 (CH), 130.9 (CH), 130.0 (CH), 128.3 (2
1H NMR (300 MHz, CDCl3): δ = 8.65 (s, 1 H), 7.80–7.57 (m, 8 H), 7.28–
7.20 (m, 10 H), 7.10–6.95 (m, 6 H), 5.56–5.45 (m, 2 H), 5.37 (d, J =
CH), 127.93 (CH), 127.90 (CH), 127.7 (2 CH), 127.6 (CH), 127.23 (CH), 8.5 Hz, 1 H), 5.09 (s, 2 H), 5.00 (d, J = 8.5 Hz, 1 H), 4.62 (AB system,
127.20 (CH), 125.6 (CH), 125.14 (CH), 125.10 (C), 123.6 (2 CH), 120.05 J = 12.5 Hz, 1 H), 4.45 (AB system, J = 12.0 Hz, 2 H), 4.38 (AB system,
(CH), 120.02 (CH), 84.2 (CH), 73.7 (CH), 73.6 (CH2), 71.6 (CH), 70.3 J = 12.5 Hz, 1 H), 4.31 (dd, J = 18.0, J = 12.0 Hz, 2 H), 4.13 (dd, J =
(CH2), 69.0 (CH2), 54.0 (CH), 46.5 (CH), 34.4 (C), 31.2 (3 CH3), 20.4
(CH3), 20.3 (CH3) ppm. 2 carbon resonances CO and 2 quaternary
10.5, J = 8.5 Hz, 1 H), 4.06–3.98 (m, 2 H), 3.78 (s, 3 H), 3.74–3.60 (m,
3 H), 3.46–3.33 (m, 4 H), 1.81 (s, 3 H), 1.75 (s, 3 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 170.9 (CO), 170.0 (CO), 167.7 (CO), 138.4 (2 C),
138.1 (C), 137.4 (C), 136.4 (CH), 134.3 (4 CH), 131.9 (2 C), 131.4 (2
C), 129.2 (CH), 129.1 (CH), 128.51 (2 CH), 128.49 (2 CH), 128.3 (2 CH),
127.9 (2 CH), 127.6 (2 CH), 127.4 (2 CH), 123.5 (4 CH), 122.0 (CH),
121.0 (CH), 97.2 (CH), 96.2 (CH), 74.4 (CH), 74.3 (CH), 73.7 (CH), 73.6
(CH2), 73.3 (CH), 72.8 (CH2), 71.2 (CH), 71.1 (CH), 69.8 (2 CH2), 67.8
(CH2), 55.0 (CH), 54.9 (CH), 53.0 (CH2), 36.3 (CH3), 20.6 (CH3), 20.5
carbon resonances (phthalimido group) are missing. IR (film): ν =
˜
2960, 1780, 1753, 1717, 1450, 1383, 1254, 1218, 1065, 1037,
718 cm–1. MS (ESI): m/z (%) = 848 (100) [M + Na]+. HRMS (ESI-TOF):
calcd. for C49H47NO9SNa [M + Na]+ 848.2869; found 848.2861.
4-(1-Methyl-3-methylimidazolium)benzyl 3-O-Acetyl-6-O-benz-
yl-2-deoxy-4-O-fluorenylmethyloxycarbonyl-2-phthalimido-ꢀ-
glucopyranosyl-(1→4)-3-O-acetyl-6-O-benzyl-2-deoxy-2-phthal-
imido-ꢀ- -glucopyranoside Hexafluorophosphate (16): Donor
D-
(CH ) ppm. 3 carbon resonances [N(CO) ] were missing. IR (film): ν =
˜
3
2
D
2869, 1776, 1746, 1713, 1385, 1226, 1045, 973, 841, 720 cm–1. MS
(ESI): m/z (%) = 1049 (100) [M – PF6]+. HRMS (ESI-TOF): calcd. for
C58H57N4O15 [M – PF6]+ 1049.3820; found 1049.3839.
15 (160 mg, 0.19 mmol, 3.0 equiv.) and acceptor 10a (50 mg,
0.06 mmol, 1.0 equiv.) were mixed, and toluene (5 mL) was added.
The solvent was then evaporated, and the residue was dried in
vacuo for 1 h. Dichloromethane (1.5 mL) was then added under
argon. The solution was stirred with molecular sieves (4 Å; 40 mg)
at room temperature for 1 h. NIS (86 mg, 0.38 mmol, 6.0 equiv.) was
then added, and the suspension was cooled to –10 °C. TfOH (2.7 μL,
0.03 mmol, 0.6 equiv.) was added, and the reaction mixture was
4-(1-Methyl-3-methylimidazolium)benzyl 3,4,6-Tri-O-acetyl-2-
benzyloxycarbonylamino-2-deoxy-ꢀ-
O-acetyl-6-O-benzyl-2-deoxy-2-phthalimido-ꢀ-
syl-(1→4)-3-O-acetyl-6-O-benzyl-2-deoxy-2-phthalimido-ꢀ-
glucopyranosyl-(1→4)-3-O-acetyl-6-O-benzyl-2-deoxy-2-phthal-
D
-glucopyranosyl-(1→4)-3-
D
-glucopyrano-
D
-
stirred for 18 h at room temperature. The mixture was then diluted imido-ꢀ-D-glucopyranoside Hexafluorophosphate (19): Donor
with dichloromethane (15 mL), and neutralized with saturated
aqueous NaHCO3 (3 mL). The molecular sieves were removed by
filtration, and the filtrate was then washed with saturated aqueous
Na2S2O3 (2 × 3 mL), dried with Na2SO4, and concentrated under
reduced pressure. The residue was washed with Et2O (3 × 5 mL) and
18[18a] (108 mg, 0.10 mmol, 3.0 equiv.) and acceptor 17 (42 mg,
0.04 mmol, 1.0 equiv.) were mixed, and toluene (5 mL) was added.
The solvent was then evaporated, and the residue was dried in
vacuo for 1 h. Dichloromethane (1.0 mL) was then added under
argon. The solution was stirred with molecular sieves (4 Å; 70 mg)
a mixture of CH2Cl2/n-pentane (4:1; 3 × 5 mL) to give compound at room temperature for 1 h. The suspension was then cooled to
1
16 (85 mg, 92 %) as a yellow foam. [α]D20 = +6.3 (c = 1.8, CHCl3). H –40 °C, and NIS (53 mg, 0.23 mmol, 6.0 equiv.) and TfOH (2.0 μL,
NMR (300 MHz, CDCl3): δ = 8.73 (s, 1 H), 7.85–7.70 (m, 8 H), 7.52 (2
0.02 mmol, 0.6 equiv.) were added. The reaction mixture was stirred
H), 7.42–7.27 (m, 12 H), 7.18–7.01 (m, 10 H), 5.83 (dd, J = 10.5, J = at room temperature for 24 h. The mixture was diluted with di-
9.0 Hz, 1 H), 5.59 (dd, J = 11.0, J = 9.0 Hz, 1 H), 5.48 (d, J = 8.5 Hz,
1 H), 5.16 (s, 2 H), 5.07 (d, J = 8.7 Hz, 1 H), 4.69 (AB system, J =
12.5 Hz, 1 H), 4.53–4.41 (m, 5 H), 4.39–4.29 (m, 2 H), 4.27–4.10 (m,
chloromethane (15 mL), and neutralized with saturated aqueous
NaHCO3 (3 mL). The molecular sieves were removed by filtration
through Celite®. The filtrate was then washed with saturated aque-
Eur. J. Org. Chem. 2016, 1103–1109
1107
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim